HBS faculty members are close to practice in diverse roles and contexts.
Since its founding, the School has been distinguished by its faculty, which is close to the practice of management. This trait has spurred ongoing innovation, generated an uncommon level of insight, and enriched course and case development. In addition to tenure-track faculty, HBS has attracted practitioners who have experience running companies or governmental agencies. These individuals become key members of the faculty, bringing a richness in backgrounds to teaching and mentoring. HBS also has reached out, through joint appointments, to other faculties of Harvard with knowledge of the sciences, humanities, and social sciences.
William C. Kirby, Professor
A world-renowned historian of modern Chinese economic and political development in an international context, William C. Kirby, Ph.D., is the Geisinger Professor of History, a Harvard University Distinguished Service Professor, and the director of the Fairbank Center for East Asian Research. He joined the HBS faculty in fall 2006 and worked with Warren McFarlan to develop a new course in the MBA elective curriculum, "Doing Business in China in the Early 21st Century."
Robert Steven Kaplan, Professor of Management Practice
In addition to his teaching role in organizational behavior at HBS, Robert Kaplan is a senior director of The Goldman Sachs Group, where he held varied leadership positions after becoming a partner in 1990. Kaplan is founding co-chair of the Advisory Board of the Harvard NeuroDiscovery Center, a member of the Board of the Harvard Medical School, and a member of the Kansas Healthcare Policy Authority Board.
Vicki L. Sato, Professor of Management Practice
A scientist and biotechnology business leader, Vicki L. Sato, Ph.D., is an advisor to enterprises in the biotechnology and pharmaceutical industries. She recently retired from Vertex Pharmaceuticals, where she served as president for seven years after holding other key positions within the company. She was formerly vice president of research at Biogen, Inc., and associate professor of biology at Harvard University. In addition to her role at HBS, she currently holds a similar appointment in Harvard's Department of Molecular and Cell Biology. Sato is co-teaching “Inventing Breakthroughs and Commercializing Science” in the MBA elective curriculum.
Clayton S. Rose, Senior Lecturer
Clayton Rose joined HBS after a 20-year career at JPMorgan Chase & Co., where he headed the Global Investment Banking and Global Equities divisions. In 2007, Rose completed a Ph.D. in sociology at the University of Pennsylvania. His dissertation examined how companies manage the racial composition of their boards and senior management teams. He also chairs Highbridge Capital Management, a $32 billion hedge fund, and has served as a director of financial services and life sciences companies.